The Reconstructive Surgery & Regenerative Medicine Research Group (ReconRegen) is a multidisciplinary team of clinicians and scientists at Swansea University investigating how the use of stem cells and tissue engineered constructs can restore the form and function of the human body.
In addition to looking at different mesenchymal cell sources and their interaction with scaffolds and the environment (biological active molecules, electrical and mechanical transduction etc), the team is also investigating the potential risk factors associated with the use of both stem cells and alloplastic alternatives.
The research aim is to complement clinical practice, and in particular, surgical reconstruction following trauma and disease. These research aims are in alignment with the UK government research agenda, who have highlighted regenerative medicine as one of ‘8 great technologies’ and a priority for strategic investment in the scientific infrastructure. Regenerative medicine has preciously been highlighted as one of the key areas which could provide global competitive advantage for the UK. REF LINK (House of Lords, Science and Technology Committee Regenerative medicine Report, July 2013). In the recent REF assessment in 2014, Swansea University was ranked joint 1st in the UK for research Environment (4*). The group has active funding from several sources including The Medical Research Council, Royal College of Surgeons (Eng), Royal College of Surgeons (Edin) and The British Association of Plastic & Reconstructive Surgeons (BAPRAS).